Mediolanum International Funds’s Alnylam Pharmaceuticals ALNY Stock Holding History

Mediolanum International Funds’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.6M	Buy	46,396 +1,277	+3%	+$385K	0.12%	186
2026 Q1	$14.3M	Buy	45,119 +2,643	+6%	+$899K	0.15%	158
2025 Q4	$16.9M	Buy	42,476 +17,025	+67%	+$7.53M	0.17%	149
2025 Q3	$11.4M	Buy	+25,451	New	+$10.4M	0.12%	183
2025 Q2	–	Sell	-34,729	Closed	-$9.32M	–	402
2025 Q1	$9.32M	Buy	34,729 +25,666	+283%	+$6.6M	0.13%	173
2024 Q4	$2.13M	Sell	9,063 -1,135	-11%	-$298K	0.03%	316
2024 Q3	$2.8M	Buy	+10,198	New	+$2.66M	0.04%	302
2024 Q2	–	Sell	-38,556	Closed	-$5.95M	–	395
2024 Q1	$5.95M	Buy	+38,556	New	+$6.43M	0.1%	207

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mediolanum International Funds's ALNY Position: Q2 2026 in Review

Mediolanum International Funds increased its Alnylam Pharmaceuticals (ALNY) stake by 2.8% in Q2 2026, buying an estimated $385K and bringing the position to 46,396 shares worth $13.6M. The position accounts for 0.12% of the portfolio, ranked #186.

Mediolanum International Funds first reported a position in ALNY in Q1 2024 and has held it in 8 quarters since. The position peaked at $16.9M in Q4 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Mediolanum International Funds held 46,396 shares of Alnylam Pharmaceuticals worth $13.6M as of Q2 2026.
Mediolanum International Funds bought 1,277 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $385K.
Alnylam Pharmaceuticals made up 0.12% of Mediolanum International Funds's portfolio in Q2 2026, its #186 holding.
Mediolanum International Funds first reported a position in Alnylam Pharmaceuticals in Q1 2024 and has held it in 8 quarters since.
Mediolanum International Funds's Alnylam Pharmaceuticals position peaked at $16.9M in Q4 2025.
793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Mediolanum International Funds's 13F filing for Q2 2026, filed 23 Jul 2026.